Steris reported $1.59B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
3M USD 6.58B 84M Sep/2026
Accuray USD 116.17M 14.63M Dec/2024
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
CONMED USD 335.6M 7.9M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.34B 30M Sep/2026
Ecolab USD 4.69B 280M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Fortive USD 1.11B 10M Sep/2026
Getinge SEK 8.38B 1000K Jun/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Haemonetics USD 357.76M 18.76M Sep/2026
Idexx Laboratories USD 1.21B 10M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
J&J USD 25.4B 89M Sep/2026
Olympus JPY 269.19B 28.79B Sep/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Steris USD 1.59B 88.6M Sep/2026
Stryker USD 6.5B 100M Sep/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026